Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 3 studies | 27% ± 5% |
Insufficient scRNA-seq data for expression of CHODL at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 91% | 503.47 | 223 / 245 | 58% | 3.75 | 289 / 502 |
ovary | 51% | 62.16 | 92 / 180 | 93% | 19.71 | 401 / 430 |
esophagus | 73% | 137.20 | 1059 / 1445 | 36% | 4.80 | 65 / 183 |
kidney | 88% | 417.08 | 78 / 89 | 15% | 1.61 | 131 / 901 |
spleen | 100% | 830.98 | 241 / 241 | 0% | 0 | 0 / 0 |
breast | 77% | 117.41 | 353 / 459 | 20% | 2.35 | 224 / 1118 |
intestine | 86% | 197.13 | 828 / 966 | 3% | 0.14 | 18 / 527 |
blood vessel | 86% | 260.37 | 1151 / 1335 | 0% | 0 | 0 / 0 |
brain | 56% | 142.29 | 1489 / 2642 | 28% | 4.69 | 200 / 705 |
thymus | 77% | 133.81 | 504 / 653 | 5% | 0.42 | 30 / 605 |
skin | 66% | 87.38 | 1195 / 1809 | 10% | 1.46 | 48 / 472 |
adipose | 62% | 183.41 | 752 / 1204 | 0% | 0 | 0 / 0 |
bladder | 43% | 75.76 | 9 / 21 | 18% | 2.03 | 91 / 504 |
lung | 8% | 4.26 | 44 / 578 | 47% | 5.59 | 541 / 1155 |
heart | 50% | 159.93 | 428 / 861 | 0% | 0 | 0 / 0 |
uterus | 12% | 9.82 | 20 / 170 | 33% | 5.72 | 150 / 459 |
tonsil | 0% | 0 | 0 / 0 | 42% | 2.26 | 19 / 45 |
stomach | 35% | 68.80 | 126 / 359 | 6% | 0.42 | 16 / 286 |
adrenal gland | 24% | 27.54 | 62 / 258 | 12% | 1.47 | 28 / 230 |
muscle | 19% | 28.40 | 150 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 17% | 0.68 | 5 / 29 |
liver | 0% | 0.56 | 1 / 226 | 6% | 1.11 | 24 / 406 |
peripheral blood | 5% | 4.08 | 46 / 929 | 0% | 0 | 0 / 0 |
pancreas | 0% | 0.16 | 1 / 328 | 3% | 0.11 | 6 / 178 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007399 | Biological process | nervous system development |
GO_0050772 | Biological process | positive regulation of axonogenesis |
GO_0007517 | Biological process | muscle organ development |
GO_0005813 | Cellular component | centrosome |
GO_0005737 | Cellular component | cytoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0030246 | Molecular function | carbohydrate binding |
GO_0005515 | Molecular function | protein binding |
GO_0005540 | Molecular function | hyaluronic acid binding |
Gene name | CHODL |
Protein name | Chondrolectin Chondrolectin (Transmembrane protein MT75) |
Synonyms | PRED12 C21orf68 UNQ872/PRO1890 |
Description | FUNCTION: May play a role in the development of the nervous system such as in neurite outgrowth and elongation. May be involved in motor axon growth and guidance. . |
Accessions | Q9H9P2 ENST00000400135.5 ENST00000400127.5 [Q9H9P2-2] ENST00000338326.4 ENST00000400131.5 ENST00000299295.7 [Q9H9P2-1] ENST00000400128.5 [Q9H9P2-2] A0A0C4DFS2 ENST00000543733.5 [Q9H9P2-4] |